+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis



Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis



Infection and Immunity 69(4): 2728-2731



The protective effects of intranasal administration of amphotericin B (AmB), human SP-A, SP-D and a 60-kDa fragment of SP-D (rSP-D) were examined in a murine model of invasive pulmonary aspergillosis (IPA). The untreated group of IPA mice showed no survival at 7 days postinfection. Treatment with AmB, SP-D, and rSP-D increased the survival rate to 80, 60, and 80%, respectively, suggesting that SP-D (and rSP-D) can protect immunosuppressed mice from an otherwise fatal challenge with Aspergillus fumigatus conidia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 003537173

Download citation: RISBibTeXText

PMID: 11254642

DOI: 10.1128/iai.69.4.2728-2731.2001


Related references

Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clinical and Experimental Immunology 148(2): 382-389, 2007

Therapeutic effects of recombinant forms of full-length and truncated human surfactant protein D in a murine model of invasive pulmonary aspergillosis. Molecular Immunology 46(11-12): 2363-2369, 2009

Protective role of a recombinant fragment of human surfactant protein D against pulmonary hypersensitivity in a murine model of dust mite allergy. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl.): S199, 2003

Pulmonary surfactant protein A and D suppress eosinophilia and specific IgE antibodies in a murine model of allergic bronchopulmonary Aspergillosis. Journal of Allergy and Clinical Immunology 105(1 part 2): S301, 2000

Protective effects of a recombinant fragment of human surfactant protein D in a murine model of pulmonary hypersensitivity induced by dust mite allergens. Immunology Letters 86(3): 299-307, 2003

Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 51(4): 1253-1258, 2007

Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 48(5): 1908-1911, 2004

Standardization of an experimental murine model of invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 50(10): 3501-3503, 2006

Role of TNF-a in pulmonary host defense in murine invasive aspergillosis. Journal of Immunology 162(3): 33-40, 1999

Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis. Medical Mycology 49(8): 834-847, 2011

In vivo pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 43: 445, 2003

Murine model to follow hyphal development in invasive pulmonary aspergillosis. Applied Microbiology and Biotechnology 102(6): 2817-2825, 2018

Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 50(10): 3464-3466, 2006

The protective effect of different airway humidification liquids to lung after tracheotomy in traumatic brain injury: The role of pulmonary surfactant protein-A (SP-A). Gene 577(1): 89-95, 2016

Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. Journal of Immunology 162(3): 1633-1640, 1999